Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Organic Compound

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1797277

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1797277

Ethylenediamine Tetraacetic Acid (EDTA) Tubes

PUBLISHED:
PAGES: 371 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5850
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market to Reach US$2.9 Billion by 2030

The global market for Ethylenediamine Tetraacetic Acid (EDTA) Tubes estimated at US$2.1 Billion in the year 2024, is expected to reach US$2.9 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2024-2030. K2 EDTA Tube, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$1.7 Billion by the end of the analysis period. Growth in the K3 EDTA Tube segment is estimated at 7.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$575.7 Million While China is Forecast to Grow at 8.5% CAGR

The Ethylenediamine Tetraacetic Acid (EDTA) Tubes market in the U.S. is estimated at US$575.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$580.6 Million by the year 2030 trailing a CAGR of 8.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.8% and 5.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.6% CAGR.

Global Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market - Key Trends & Drivers Summarized

Why Are EDTA Tubes Considered Essential in Modern Diagnostic and Clinical Laboratories?

Ethylenediamine tetraacetic acid (EDTA) tubes are commonly used blood collection containers pre-coated with EDTA as an anticoagulant. These tubes are critical for hematology tests because EDTA effectively binds calcium ions, preventing clot formation and preserving blood cell morphology. They are widely used for complete blood counts (CBC), blood typing, molecular diagnostics, and various DNA or RNA-based tests.

The precision and reliability of blood-based diagnostics heavily depend on the integrity of the collected specimen. EDTA tubes maintain cellular structure for hours after collection, enabling accurate analysis of white and red blood cells, platelets, and nucleic acids. Their widespread use across hospitals, diagnostic labs, blood banks, and research facilities makes them indispensable in routine and specialized laboratory workflows.

What Are the Emerging Material and Design Improvements in EDTA Tubes?

Manufacturers are refining EDTA tubes through improvements in material quality, closure systems, and anticoagulant formulations. Most tubes are made of glass or plastic (polyethylene terephthalate or polypropylene), with plastic variants gaining preference due to their reduced breakage risk and lighter weight. Innovations include screw caps, safety closures, and vacuum-sealed designs to ensure contamination-free collection and processing.

Uniform coating of spray-dried or liquid EDTA ensures consistent anticoagulant action. Color-coded caps, primarily lavender or purple, are standardized across regions to facilitate quick identification in labs. Some manufacturers are integrating barcode labels, volume indicators, and RFID chips for improved tracking and sample handling. Additions such as gel separators or clot activators are also being explored for specific use cases, enhancing sample quality across diverse diagnostics.

Where Is Demand Expanding, and Who Are the Core End-Users?

EDTA tube demand is expanding globally due to the increasing number of diagnostic procedures and the rising burden of chronic and infectious diseases. Core users include clinical laboratories, hospitals, pathology labs, blood banks, biobanks, and academic research centers. Rapid growth in preventive screening, personalized medicine, and infectious disease testing has also increased the frequency of blood draws, thereby fueling tube usage.

High-volume markets include North America and Europe, supported by advanced healthcare infrastructure and routine use of automated hematology analyzers. Asia Pacific is witnessing strong growth due to expanding diagnostic networks, urban healthcare access, and rising investments in laboratory automation. In emerging markets, government programs for public health diagnostics are contributing to increased procurement of standardized blood collection systems.

What Is Driving Growth in the EDTA Tubes Market?

Growth in the EDTA tubes market is driven by several factors including rising global diagnostic volumes, increased focus on blood-based disease screening, and the expanding reach of clinical laboratories. Technological improvements in blood collection systems, enhanced compatibility with automated analyzers, and better anticoagulant stability are reinforcing product relevance.

End-use expansion in molecular diagnostics, cancer genomics, and population health studies is increasing reliance on EDTA-preserved blood samples. Growth in home diagnostics and point-of-care testing is also supporting innovation in portable and safe blood collection devices. As healthcare delivery systems become more diagnostic-centered and lab automation increases, EDTA tubes will continue to be a foundational element of clinical sample management.

SCOPE OF STUDY:

The report analyzes the Ethylenediamine Tetraacetic Acid (EDTA) Tubes market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (K2 EDTA Tube, K3 EDTA Tube); Application (Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application, Other Applications); End-Use (Hospitals End-Use, Diagnostics Centers End-Use, R&D Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

  • AdvaCare Pharma
  • APT Medical
  • BD - Becton, Dickinson and Company
  • CDRICH
  • F.L. Medical srl
  • Gong Dong (Zhejiang Gongdong)
  • Greiner Bio-One AG (GBO)
  • Guangzhou Jiuan Medical Equipment Co. Ltd
  • Haemonetics Corp.
  • Hongyu Medical
  • Improve Medical
  • Medtronic PLC
  • Narang Medical Pvt Ltd
  • Sanli Medical
  • Sarstedt AG & Co.
  • Sekisui Diagnostics
  • Shanghai Biyun Medical Technology Co. Ltd
  • Terumo Corporation
  • TUD (Tianjin Union Development)
  • Vitrex Medical A/S

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP38799

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Ethylenediamine Tetraacetic Acid (EDTA) Tubes - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Focus on Preventive Healthcare and Diagnostic Testing Drives Demand for EDTA Blood Collection Tubes
    • Expansion of Clinical Laboratory Infrastructure in Emerging Markets Strengthens Market Penetration of EDTA Tubes
    • Increasing Incidence of Infectious and Chronic Diseases Spurs Routine Use of EDTA Tubes in Hematological Testing
    • Standardization of Blood Sample Collection Protocols in Hospitals Enhances Demand for Pre-Prepared EDTA Tubes
    • OEM Innovation in Non-Glass, Shatterproof Tube Materials Supports Safety and Convenience in Sample Handling
    • Regulatory Compliance for Blood Sample Preservation Drives Preference for EDTA Tubes in Plasma and CBC Testing
    • Growth in Global Blood Donation and Transfusion Services Sustains Large-Scale Demand for EDTA Tubes in Blood Banks
    • Automation in Diagnostic Laboratories Throws the Spotlight on EDTA Tubes with Robotic Compatibility and Barcode Labeling
    • Increased Adoption of Vacuum Blood Collection Systems Enhances Efficiency and Reduces Contamination R
    • Integration of EDTA Tubes in Point-of-Care Testing and Mobile Health Clinics Expands Access in Rural and Remote Settings
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for K2 EDTA Tube by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for K2 EDTA Tube by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for K2 EDTA Tube by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for K3 EDTA Tube by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for K3 EDTA Tube by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for K3 EDTA Tube by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for R&D Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for R&D Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for R&D Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Diagnostics Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Diagnostics Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Diagnostics Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Complete Blood Count Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Complete Blood Count Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Complete Blood Count Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Blood Smear Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Blood Smear Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Blood Smear Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Coagulation Tests Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Coagulation Tests Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: World 16-Year Perspective for Coagulation Tests Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Bone Marrow Biopsy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Bone Marrow Biopsy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: World 16-Year Perspective for Bone Marrow Biopsy Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
  • JAPAN
    • Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
  • CHINA
    • Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: China 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: China 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: China 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
  • EUROPE
    • Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
  • FRANCE
    • Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: France 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: France 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: France 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
  • GERMANY
    • Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: UK 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: Spain 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: Spain 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Spain 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Russia 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Russia 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Russia 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Australia 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Australia 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Australia 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
  • INDIA
    • Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 170: India Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: India 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: India 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: India 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: South Korea 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: South Korea 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: South Korea 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Latin America 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Latin America 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Latin America 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 211: Argentina 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 214: Argentina 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 217: Argentina 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 220: Brazil 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 223: Brazil 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 226: Brazil 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 229: Mexico 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 232: Mexico 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 235: Mexico 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 250: Middle East 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 253: Middle East 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 256: Middle East 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 259: Iran 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 262: Iran 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 265: Iran 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 268: Israel 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 271: Israel 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 274: Israel 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 286: UAE 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 289: UAE 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 292: UAE 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
  • AFRICA
    • Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 304: Africa 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 307: Africa 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 310: Africa 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!